Latest profit margin
Scribe Therapeutics Profit margin
Direct answer
Scribe Therapeutics's profit margin is -97%.
The verified market snapshot reports -97%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Scribe Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Profit margin
- -97%